Will the Phase 2/Phase 3 trial "Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer." reach primary completion on or before Dec 27, 2029?

Resolves Yes if ClinicalTrials.gov record NCT06758830 (National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos) shows an actual primary completion date on or before Dec 27, 2029. Registered date at generation: Dec 27, 2029.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Dec 27, 2029, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.